29) While there was no significant difference seen in the primary outcome of exercise tolerance, a positive trend was seen in favour of omapatrilat in reducing the composite of death, admission or discontinuation of study treatment for worsening HF.
← all excerpts
Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction.
1
—
—